Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
The New England Journal of Medicine|November 19, 2004
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cellsSandeep S Dave, George Wright, Bruce Tan, et al.
Cancer Cell|March 7, 2003
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphomaAndreas Rosenwald, George Wright, Adrian Wiestner, et al.
Blood Advances|July 17, 2025
High-grade B-cell lymphoma, not otherwise specified: an LLMPP studyBrett J Collinge, Laura K Hilton, Jasper Chun Hei Wong, et al.
Blood Cancer Discovery|May 8, 2025
DNA methylation epitypes of Burkitt lymphoma with distinct molecular and clinical featuresNicole Thomas, Carlos A García-Prieto, Kostiantyn Dreval, et al.
The New England Journal of Medicine|June 21, 2002
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphomaAndreas Rosenwald, George Wright, Wing C Chan, et al.
Blood|October 8, 2021
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphomaAnne C Wilke, Carmen Doebele, Alena Zindel, et al.
Cancer Cell|November 20, 2020
Molecular Features of Cancers Exhibiting Exceptional Responses to TreatmentDavid A Wheeler, Naoko Takebe, Toshinori Hinoue, et al.
Blood|February 21, 2019
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaTayla B Heavican, Alyssa Bouska, Jiayu Yu, et al.
Blood|January 9, 2019
Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphomaBruno M Grande, Daniela S Gerhard, Aixiang Jiang, et al.
Nature Medicine|February 26, 2020
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphomaDaisuke Ennishi, Shannon Healy, Ali Bashashati, et al.
Pageof 27